These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile. Turner NA; Warren BG; Gergen-Teague MF; Addison RM; Addison B; Rutala WA; Weber DJ; Sexton DJ; Anderson DJ Clin Infect Dis; 2022 Mar; 74(4):648-656. PubMed ID: 34017999 [TBL] [Abstract][Full Text] [Related]
16. Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile. Phanchana M; Phetruen T; Harnvoravongchai P; Raksat P; Ounjai P; Chankhamhaengdecha S; Janvilisri T Sci Rep; 2020 Apr; 10(1):6497. PubMed ID: 32300130 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile. Collins DA; Wu Y; Tateda K; Kim HJ; Vickers RJ; Riley TV J Antimicrob Chemother; 2021 Mar; 76(4):967-972. PubMed ID: 33351917 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability? Chiu CW; Tsai PJ; Lee CC; Ko WC; Hung YP J Microbiol Immunol Infect; 2021 Dec; 54(6):1011-1017. PubMed ID: 34229970 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017. Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]